The convergence of life and health insurance continued unabated this year, spurred by regulatory support and a recognition that preventative healthcare is a far more attractive proposition for consumers than pure reimbursement of medical costs.
Although chronic disease management has always been a key principle of preventative healthcare, the ability to integrate hardware and software is still a rare feat amongst MedTech startups but one who is delivering on this is Beijing based Dnurse.
The problem Dnurse is tackling is a significant one. China now has 110 million diabetics, 70% of who are still undiagnosed, and 80% of the costs relating to diabetes stem from the treatment of complications arising from the mismanagement of diabetes as opposed to inevitable symptoms.
Two key innovations have marked out Dnurse as the leading diabetes management app in China. The first is an insulin pen coupled with an AI driven recommendation engine called the IDSS (Intelligent Decision Supporting System). The IDSS utilizes the processing power of smartphones and Dnurse operated cloud servers to analyse blood glucose levels and insulin dosages in real time before delivering personalised recommendations to diabetes sufferers. The IDSS also integrates with both the patient and doctor Dnurse app, enabling seamless doctor-patient communication and minimising the response time in cases of seizure or overdose.
The second innovation at Dnurse is Insulink, an insulin dosage monitor that records insulin dosages before uploading this data to the Dnurse platform, ultimately helping diabetics to efficiently manage their blood glucose levels and treatment routine. Additionally, Insulink generates a data log that is further analysed by the Dnurse IDSS and again pushed to Dnurse users and user nominated doctors.
These actions at Dnurse have not gone unnoticed by China’s health and life insurers. Taikang Life recently partnered with Dnurse to launch a diabetes product called ‘Sweet Life’ and Dnurse is now being integrated directly into the homepage of Ping An Good Doctor, which brings access to 300 million active users.
Ultimately, although a number of chronic disease management products emerged this year, Dnurse has marked itself out with an ability to integrate hardware and software in a way that benefits both consumers – by improves the health outcomes of its users, and insurers – by positioning insurers in a preventative rather than reactive role, one that many insurers are striving for as consumers increasingly seek products that benefit their daily lives as opposed to the consequences of misfortune.
To read the latest insurance innovation news and features in Chinese on WeChat visit our page at: